Credit Agricole’s Anavex Life Sciences AVXL Stock Holding History

Credit Agricole’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1	Closed	–	–	469
2019 Q4	$0	Hold	1	–	–	﹤0.01%	444
2019 Q3	$0	Buy	+1	New	+$3	﹤0.01%	510

Other funds holding AVXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Credit Agricole's AVXL Position: Q1 2020 in Review

Credit Agricole sold out of Anavex Life Sciences (AVXL) in Q1 2020, closing a stake of 1 share.

Credit Agricole first reported a position in AVXL in Q3 2019 and held it in 2 quarters. The position peaked at $0 in Q4 2019. 70 funds tracked by Wall St. Rank hold AVXL as of Q1 2020.

Credit Agricole reported no remaining Anavex Life Sciences position as of Q1 2020 after selling out during the quarter.
Credit Agricole sold 1 Anavex Life Sciences share in Q1 2020.
Credit Agricole first reported a position in Anavex Life Sciences in Q3 2019 and held it in 2 quarters.
Credit Agricole's Anavex Life Sciences position peaked at $0 in Q4 2019.
70 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2020.

Based on Credit Agricole's 13F filing for Q1 2020, filed 14 May 2020.